Giménez-Palop, O.; Casamitjana, L.; Corripio, R.; Esteba-Castillo, S.; Pareja, R.; Albiñana, N.; Rigla, M.; Caixàs, A.
Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader–Willi Syndrome. J. Clin. Med. 2021, 10, 3054.
https://doi.org/10.3390/jcm10143054
AMA Style
Giménez-Palop O, Casamitjana L, Corripio R, Esteba-Castillo S, Pareja R, Albiñana N, Rigla M, Caixàs A.
Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader–Willi Syndrome. Journal of Clinical Medicine. 2021; 10(14):3054.
https://doi.org/10.3390/jcm10143054
Chicago/Turabian Style
Giménez-Palop, Olga, Laia Casamitjana, Raquel Corripio, Susanna Esteba-Castillo, Rocío Pareja, Néstor Albiñana, Mercedes Rigla, and Assumpta Caixàs.
2021. "Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader–Willi Syndrome" Journal of Clinical Medicine 10, no. 14: 3054.
https://doi.org/10.3390/jcm10143054
APA Style
Giménez-Palop, O., Casamitjana, L., Corripio, R., Esteba-Castillo, S., Pareja, R., Albiñana, N., Rigla, M., & Caixàs, A.
(2021). Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader–Willi Syndrome. Journal of Clinical Medicine, 10(14), 3054.
https://doi.org/10.3390/jcm10143054